Related references
Note: Only part of the references are listed.IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer
Li Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
Karin M. Knudson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
M2 macrophages promote NSCLC metastasis by upregulating CRYAB
Zhe Guo et al.
CELL DEATH & DISEASE (2019)
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector
Wenjuan Dong et al.
CANCER DISCOVERY (2019)
M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer
Lili Cao et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade
Lee P. Richman et al.
CELL SYSTEMS (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma
Paul Zolkind et al.
ONCOTARGET (2018)
Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer
Yoshikane Yamauchi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
Rizwan Romee et al.
BLOOD (2018)
Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells
Brian J. Morrison et al.
BMC CANCER (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
Sonam Puri et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M. Wrangle et al.
LANCET ONCOLOGY (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Rebekka Weber et al.
FRONTIERS IN IMMUNOLOGY (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors
Kim Margolin et al.
CLINICAL CANCER RESEARCH (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer
Jennifer Brooks et al.
CANCER RESEARCH (2018)
Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy
Gilles Jobin et al.
GASTROENTEROLOGY (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Humanized mouse model supports development, function, and tissue residency of human natural killer cells
Dietmar Herndler-Brandstetter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
Stephan Halle et al.
TRENDS IN IMMUNOLOGY (2017)
IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities
Sigrid Dubois et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Cancer immunotherapy: Historical Perspective of a Clinical Revolution and emerging Preclinical Animal Models
William K. Decker et al.
FRONTIERS IN IMMUNOLOGY (2017)
Immunobiology of the IL-15/IL-15Rα complex as an antitumor and antiviral agent
Yin Guo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors
Harriet M. Kluger et al.
CLINICAL CANCER RESEARCH (2017)
Immune checkpoints and their inhibition in cancer and infectious diseases
Lydia Dyck et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Escape from IFN-γ-dependent immunosurveillance in tumorigenesis
Chiou-Feng Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model
Dimitrios Mathios et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models
Peter R. Rhode et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap
J. Jason Morton et al.
CANCER RESEARCH (2016)
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
Marco De Simone et al.
IMMUNITY (2016)
NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells
Ximena L. Raffo Iraolagoitia et al.
JOURNAL OF IMMUNOLOGY (2016)
Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer
Kazuhiko Shien et al.
LUNG CANCER (2016)
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
Sung-Yup Cho et al.
MOLECULES AND CELLS (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
Peter S. Kim et al.
ONCOTARGET (2016)
In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition
Nicola Tumino et al.
AIDS (2015)
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
Hui-Ming Chen et al.
CLINICAL CANCER RESEARCH (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
T-cell exhaustion in the tumor microenvironment
Y. Jiang et al.
CELL DEATH & DISEASE (2015)
ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis
Jian Liu et al.
CELL REPORTS (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Donald T. Weed et al.
CLINICAL CANCER RESEARCH (2015)
Examining the utility of patient-derived xenograft mouse models
Samuel Aparicio et al.
NATURE REVIEWS CANCER (2015)
Clinical evaluation of systemic and local immune responses in cancer: time for integration
Dmitriy W. Gutkin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells
A. El-Gazzar et al.
ONCOGENE (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Clinical Impact of Tumor-infiltrating Lymphocytes for Survival in Curatively Resected Stage IV Colon Cancer with Isolated Liver or Lung Metastasis
Won-Suk Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Enhancement of Antitumor Immunity in Lung Cancer by Targeting Myeloid-Derived Suppressor Cell Pathways
Anandi Sawant et al.
CANCER RESEARCH (2013)
Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
Despina Siolas et al.
CANCER RESEARCH (2013)
Natural killer cell deficiency
Jordan S. Orange
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Reduction of the CD16-CD56bright NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
Kyo Chul Koo et al.
PLOS ONE (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
New generation humanized mice for virus research: Comparative aspects and future prospects
Ramesh Akkina
VIROLOGY (2013)
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2011)
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Srinivas Nagaraj et al.
CLINICAL CANCER RESEARCH (2010)
Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity
Anil Shanker et al.
IMMUNOLOGY (2010)
Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b(+)/CD14(-)/CD15(+)/CD33(+) myeloid-derived suppressor cells and CD8(+) T lymphocytes in patients with advanced-stage non-small cell lung cancer
Chien-Ying Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Long-Term Human CD34+ Stem Cell-Engrafted Nonobese Diabetic/SCID/IL-2Rγnull Mice Show Impaired CD8+ T Cell Maintenance and a Functional Arrest of Immature NK Cells
Maya C. Andre et al.
JOURNAL OF IMMUNOLOGY (2010)
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Richard E. Royal et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Evolutionary struggles between NK cells and viruses
Lewis L. Lanier
NATURE REVIEWS IMMUNOLOGY (2008)
CD8 T cell help for innate antitumor immunity
Anil Shanker et al.
JOURNAL OF IMMUNOLOGY (2007)
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Carolyn E. Clark et al.
CANCER RESEARCH (2007)
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Arlene H. Sharpe et al.
NATURE IMMUNOLOGY (2007)
Familial NK cell deficiency associated with impaired IL-2-and IL-15-dependent survival of lymphocytes
Celine Eidenschenk et al.
JOURNAL OF IMMUNOLOGY (2006)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies
Hongbin Ji et al.
CANCER CELL (2006)
PTEN expression in non-small-cell lung cancer:: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration
CJ Marsit et al.
HUMAN PATHOLOGY (2005)
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells
YE Latchman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
MK Kennedy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
The emerging role of IL-15 in NK-cell development
CC Liu et al.
IMMUNOLOGY TODAY (2000)
Share Paper
